clinic ......services for european distribution. sanaclis was founded in 2000 by seasoned industry...
TRANSCRIPT
PROVENTAI N T E R N A T I O N A L
Andrea Small-Howard Chief Security Officer GB Sciences
Anthony Zuccarello Director, Dev. Supply Chain CMC Rocket Pharmaceuticals
Atif Abbas Vice President, Oncology Clinical Dev.Spring Bank Pharmaceuticals
Dale Dhanoa CEO INVENT Pharmaceuticals
Kevin Ryan VP & Chief Compliance Officer ACADIA
Mohammed Ahmad Medical Director Head of Medical Clinical QualityTakeda Pharmaceuticals
Ben Exter VP & Head of Pharmacovigilance Unum Therapeutics
Jack Fernandes CEO Regenica Biosciences
Abhit Singh Chief Regulatory OfficerIntrommune Therapeutics
Atul Deshpande Chief Strategy Officer & Head US OperationsHarbour Biomed
SPONSORS
HOTEL & TRAVEL
SAN DIEGO
2020
OUR UNIQUE MEETING FORMAT
Roundtable Discussions These interactive and informal discussion groups are the hallmark of the meeting. The brightest minds in the industry are brought together in 60-minute sessions that enable participants to share ideas, challenges and lessons learned.
Personalised AgendaEach delegate receives a personalised agenda with the roundtable discussions that you choose. You only attend sessions and meetings that fit your challenges and interests, ensuring your time out of the office is focused and well-utilised.
One-to-one MeetingsThe most effective and time efficient way to assess potential partners at a strategic level. Gain access to our exclusive networking app to identify the people that you need to meet. The app suggests a suitable time and place, all you need to do is grab the coffee.
Strategic NetworkingStrategic networking opportunities form a key benefit of the meeting. Our proven format for building and strengthening alliances is underscored by a host of networking programmes, from a buffet breakfast through to evening drinks, make lasting connections that benefit you.
CONTRIBUTORS TO THE AGENDA
STRATEGY MEETING WEST COAST
11thMAY
AGENDA
TRACK 2 PATIENT RECRUITMENT & CENTRICITY
TRACK 1RISK BASED MONITORING
2019 ATENDEES
TRACK 4 EMERGING BIOPHARMA
TRACK 3 OUTSOURCING
TRACK 6 STORAGE & DISTRIBUTION
TRACK 5 CLINICAL DATA & IRT
TRACK 8 ADVERSE EVENTS / CASE PROCESING
TRACK 7 SIGNAL DETECTION
TRACK 9 A.I. & MACHINE LEARNING
TRACK 10 INVESTMENTS & VENTURE CAPITAL
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
http://
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
1 - 1 MEETING *10:20-10:40 1 - 1 MEETING *10:40-11:00
Ketty Belizaire - Senior DirectorMylan
Andrea Small-Howard - CSOGB Sciences
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
How to develop a Monitoring Plan to incorporate a risk-based approach
Exploring how RBM data can be used to drive study quality
Develop a monitoring plan which focuses on mitigating risks at both the program and study levels decision-making
AFTERNOON COFFEE BREAK
DRINKS & CANAPE RECEPTION
Implementation of innovative approaches to achieve Proof-of-Concept results in record time in Early Phase Clinical Trials?
Strategies to successfully match and recruit eligible patients to clinical trials
Patient recruitment using field-based advocacy
How are the CROs addressing the demand for specialized services?
The impact of future technology on the design and execution of Phase I/II trials. New technologies, Remote Clinical trials. Newtechnologies & Remote Clinical trials.
Turning ‘High Value Study’ Feasibility into successful trial execution
How a shared-risked partnership model can improve the success rates of getting to IND and beyond
Emerging biopharma growth by partnering with VC, Pharma companies and CDMO/CRO
Does one size fit all when you are an EBP? The pros and cons in working with a Small CRO vs a Large CRO
How IRT integrations can support global multilingual studies, streamlining delivery and eliminating multi vendor coordination to improve clinical trials
How eConsent can improve sponsor and CRO oversight and ensure enrollment are meeting timelines
How to better leverage the power of multiple disparate systems and access real-time data to make better informed decisions
The need for smarter and more advanced storage and distribution facilities as part of the supply chain
How the explosive growth of Biologics has changed the Cold-Chain Clinical Supplie Chain landscape
Centralized or Decentralised Warehousing: The pros and cons for each solution
Identifying the latest development & innovation approach for effective signal management
Signal Management: meeting the needs of all stakeholders
Applying signal detection proficiency in the Sentinel System
How improving performance while reducing complexity can enable real-time signal detection for pro-active monitoring
Discovering solutions for drug counterfeiting issues & analyzing viable measures to combat & protect consumers
PV: Maintaining compliance through advanced drug safety surveillance
The A.I Paradigm Shift -Is It Just a Hype
Enhancing patient safety with A.I.
Enabling PVO in predictive science with the application of A.I.
TRACK & ROOM
8:00 - 8:30 a.m.
RISK BASED MONITORING
4:30 - 5:30 p.m.
8:30 - 9:00 a.m.
6:00 - 7:00 p.m.
9:00 - 10:00 a.m.
10:00 - 11:00 a.m.
11:00 - 12:00 a.m.
12:00 - 1:00 p.m.
2:30 - 3:00 p.m.
3:00 - 4:00 p.m.
4:00 - 4:10 p.m.
4:10 - 4:30 p.m.
REGISTRATION & BREAKFAST NETWORKING
PATIENT RECRUITMENT & CENTRICITY OUTSOURCING EMERGING BIOPHARMA CLINICAL DATA & IRT STORAGE & DISTRIBUTION SIGNAL DETECTION ADVERSE EVENTS CASE PROCESSING
A.I. & MACHINE LEARNING
01 02 03 04 05 06 07 08 09
AGENDA AT A GLANCE
NETWORKING BREAK1 - 1 MEETING *10:00-10:20 NETWORKING BREAK
3 COURSE NETWORKING LUNCH
1 - 1 MEETING *20min 1 - 1 MEETING *20minNETWORKING BREAK1 - 1 MEETING *20min NETWORKING BREAK
GO TO MENU
1 - 1 MEETING *12:00-12:20 1 - 1 MEETING *12:20-12:40 1 - 1 MEETING *12:40-13:00
1 - 1 MEETING *13:30-13:50 1 - 1 MEETING *13:50-14:10 1 - 1 MEETING *14:10-14:30
AFTERNOON COFFEE BREAKAFTERNOON COFFEE BREAK
REGISTRATION & BREAKFAST NETWORKING
DRINKS & CANAPE RECEPTIONDRINKS & CANAPE RECEPTION
Kevin Ryan - VP & CCO ACADIA
Abhit Singh - Chief Regulatory OfficerIntrommune Therapeutics
Atif Abbas - Vice PresidentSpring Bank Pharmaceuticals
Dale Dhanoa - CEOINVENT Pharmaceuticals
Anthony Zuccarello - DirectorRocket Pharmaceuticals
Reddy Tummala - Vice PresidentKaryopharm Therapeutics
Mohammed Ahmad - Director & HeadTakeda Pharmaceuticals
Atul Deshpande - CSO & HeadHarbour Biomed
Gabriel Lazarin - Vice PresidentDeepcell
Melissa Morandi - Vice PresidentAegerion Pharmaceuticals
Melissa Peirsel - Manager IRT Services
Gajanan Bhat - VP Clinical ScienceSpectrum Pharmaceuticals
Benjamin Exter - VP & HeadUnum Therapeutics
Melissa Rossi - Senior DirectorModerna Inc
Jack Fernandes - CEORegencia Biosciences
Renu Weerasinghe - Global LeadTakeda
Oliver Steinbach - VP R&DImagion Biosystems
Ashraf Yousef - Sr. Med. Director Shire
Kevin Buckley - Sr. VP HUYA Bioscience Int.
3 COURSE NETWORKING LUNCH
5:30 - 6:00 p.m. INVESTOR’S PANEL INVESTOR’S PANEL THE INVESTOR PANEL
The Ten Most Important Risk Factors to Address in order to Maintain “Real Time” Inspection-Ready TMFs
Tamika Jackson - CEO
NEXT PAGEPREVIOUS PAGE
Joanne McCaigue - DirectorPosieda Therapeutics
Catherynne Cruz - Scheckner Ionis Pharmaceuticals
WELCOME SPEECH & INVESTOR’S PANEL DISCUSSION
1:00 - 1:30 p.m. KEYNOTE PRESENTATION KEYNOTE PRESENTATIONKEYNOTE PRESENTATION
1:30 - 2:30 p.m.
The Ten Most Important Risk Factors to Address in order to Maintain “Real Time” Inspection-Ready TMFs
Tamika Jackson - CEO
The Ten Most Important Risk Factors to Address in order to Maintain “Real Time” Inspection-Ready TMFs
Tamika Jackson - CEO
Karen Giraudo - Assoc. Director BioMarin
1
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 1 RISK BASED MONITORING
Kevin Ryan VP and Cheif Compliance
ACADIA
How to develop a Monitoring Plan to incorporate a risk-based approach.
ROUNDTABLE TOPIC
GO TO MENU NEXT PAGE
TIME SLOT9:00 - 10:00 a.m.
SPEAKER TBC TBC TBC
Exploring how RBM data can be used to drive study quality.
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
SPEAKER TBC TBC
IQVIA
Optimizing and adopting use of RBM data for predictive analytics and clinical ops decision-making.
TIME SLOT11:00 - 12:00 a.m.
Develop a monitoring plan which focuses on mitigating risks at both the program and study levels
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
SPEAKER TBC TBC TBC
2
+ INFO ABOUT OUR SPEAKERS
PREVIOUS PAGE
SPONSOR ROUNDTABLE TOPIC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 2PATIENT RECRUITMENTPATIENTE CENTRICITY
Abhit Singh Chief Regulatory Officer
Intrommune Therapeutics
Implementation of innovative approaches to achieve Proof-of-Concept results in record time in Early Phase Clinical Trials?
ROUNDTABLE TOPIC
GO TO MENU NEXT PAGE
TIME SLOT9:00 - 10:00 a.m.
Gabriel Lazarin VP Clinical & Business Dev.
Deepcell
Strategies to successfully match and recruit eligible patients to clinical trials.
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
SPEAKER TBC TBC
IQVIA
How does patient- focused strategy improve business outcomes?
TIME SLOT11:00 - 12:00 a.m.
Patient recruitment using field-based advocacy.
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
Jack Fernandes CEO
Regenica Biosciences
3
+ INFO ABOUT OUR SPEAKERS
PREVIOUS PAGE
SPONSOR ROUNDTABLE TOPIC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 3PATIENT RECRUITMENTPATIENTE CENTRICITY
Atif Abbas Vice President
Spring Bank Pharmaceuticals
How are the CROs addressing the demand for specialized services?
ROUNDTABLE TOPIC
GO TO MENU NEXT PAGE
TIME SLOT9:00 - 10:00 a.m.
Melissa Morandi VP President Global QualityAegerion Pharmaceuticals
Clinical Trial of the future: what is the impact of future technology on the design and exe-cution of Phase I/II trials? New technologies, Remote Clinical trials, etc.
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
SPEAKER TBC TBC TBC
Challenges in feasibility assessments, budg-eting and overall planning for increasinglycomplex Phase I/II patient trials with adaptive designs
TIME SLOT11:00 - 12:00 a.m.
“Turning ‘High Value Study’ Feasibility into successful trial execution”
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
Ketty Belizaire Senior Director
Mylan
4
+ INFO ABOUT OUR SPEAKERS
PREVIOUS PAGE
SPONSOR ROUNDTABLE TOPIC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 4EMERGING BIOPHARMA
Dale Dhanoa CEO
Invent Pharmaceutical
How a shared-risked partnership model can improve the success rates of getting to IND and beyond?
ROUNDTABLE TOPIC
GO TO MENU NEXT PAGE
TIME SLOT9:00 - 10:00 a.m.
Gajanan Bhat VP Clinical Science/Biostatics
Spectrum Pharmaceuticals
Emerging biopharma growth by partnering with VC, Pharma companies and CDMO/CRO - TBC
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
SPEAKER TBC TBC
SANACLIS
The challenges aligned with clinical trial planning through to trial design implemen-tation and how an integrated CRO with ther-apeutically focused expertise can help?
TIME SLOT11:00 - 12:00 a.m.
Does one size fit all when you are an EBP? The decision to work with a Small vs Large CRO - The pros and cons in working with a Small CRO vs a Large CRO? Closer Relation-hips, Boutique, Local Reach vs Financial Sta-bility, Cross Therapuetic Expertise and Glob-al Resources?
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
Andrea Small-Howard CSO
GB Sciences
5
+ INFO ABOUT OUR SPEAKERS
PREVIOUS PAGE
SPONSOR ROUNDTABLE TOPIC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 5CLINICAL DATA & IRT
Anthony Zuccarello Director Dev. Supply Chain
Rocket Pharmaceuticals
How IRT integrations can support global multilingual studies, streamlining delivery and eliminating multi vendor coordination to improve clinical trials.
ROUNDTABLE TOPIC
GO TO MENU NEXT PAGE
TIME SLOT9:00 - 10:00 a.m.
Joanne McCaigue Director, DM & Programming
Statistical & Data Sciences Posieda Therapeutics
How to better leverage the power of multi-ple disparate systems and access real-time data to make better informed decisions.
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
Melissa Peirsel SCSUS Manager IRT Services
Sharp Clinical Services
How to effectively pick and utilize IRT to better support your supply design.
TIME SLOT11:00 - 12:00 a.m.
How to better leverage the power of multi-ple disparate systems and access real-time data to make better informed decisions
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
Speaker TBC TBC TBC
6
+ INFO ABOUT OUR SPEAKERS
PREVIOUS PAGE
SPONSOR ROUNDTABLE TOPIC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 6STORAGE AND DISTRIBUTION
SPEAKER TBC TBC TBC
The need for smarter and more advanced storage and distribution facilities as part of the supply chain.
ROUNDTABLE TOPIC
GO TO MENU NEXT PAGE
TIME SLOT9:00 - 10:00 a.m.
Karen Giraudo Associate Director Technical
Ops and Supply ChainBioMarin
How the explosive growth of Biologics has changed the Cold-Chain Clinical Supplies Chain landscape?
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
SPEAKER TBC TBC TBC
Rapid growth of complex protocols impedes efficiency and skyrocketed cost of clinical supply chain.
TIME SLOT11:00 - 12:00 a.m.
Centralized or Decentralised Warehousing: What are the pros and cons for each solu-tion?
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
Catherynne Cruz-SchecknerDirector Clinical Supplies Ionis Pharmaceuticals
7
+ INFO ABOUT OUR SPEAKERS
PREVIOUS PAGE
SPONSOR ROUNDTABLE TOPIC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 7SIGNAL DETECTION
Reddy Tummala VP Pharmacovigilance
Karyopharm Therapeutics
Signal Management: meeting the needs of all stakeholders
ROUNDTABLE TOPIC
GO TO MENU NEXT PAGE
TIME SLOT9:00 - 10:00 a.m.
Benjamin Exter VP & Head of Pharmacovigilance
Unum Therapeutics
Identifying the latest development & innovation approach for effective signal management
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
SPEAKER TBC TBC TBC
Why the need to address validation, analysis prioritisation, assessment is crucial to man-aging signals?
TIME SLOT11:00 - 12:00 a.m.
Applying signal detection proficiency in the sentinel system
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
Renu Weerasinghe Global Safety Lead
Takeda
8
+ INFO ABOUT OUR SPEAKERS
PREVIOUS PAGE
SPONSOR ROUNDTABLE TOPIC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 8ADVERSE EVENTSCASE PROCESSING
Mohammed Ahmad Medical Director, Head of
Medical Review Takeda Pharmaceuticals
How improving performance while reduc-ing complexity can enable real-time signal detection for pro-active monitoring?
ROUNDTABLE TOPIC
GO TO MENU NEXT PAGE
TIME SLOT9:00 - 10:00 a.m.
Melissa Rossi Sr. Director Pharmacovigilance
Mederan Inc.
Discovering solution for drug counterfeiting issues & analyzing viable measures to com-bat & protect consumers.
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
SPEAKER TBC TBC
IQVIA
Enabling a faster response by improving ad-verse event terminology reducing possible ambiguities?
TIME SLOT11:00 - 12:00 a.m.
PV: Maintaining compliance through advanced drug safety surveillance.
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
Ashraf Yousef Sr. Medical Director, Immunology & Devices, Global Safety Lead
Mylan
9
+ INFO ABOUT OUR SPEAKERS
PREVIOUS PAGE
SPONSOR ROUNDTABLE TOPIC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 9A.I & MACHINE LEARNING
Atul Deshpande Chief Strategy Officer & Head US Operations
Harbour Biomed
The A.I Paradigm Shift - Is It Just a Hype?
ROUNDTABLE TOPIC
GO TO MENU NEXT PAGE
TIME SLOT9:00 - 10:00 a.m.
Oliver Steinbach VP R&D
Imagion Biosystems
Enhancing patient safety with Artificial Intelligence
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
SPEAKER TBC TBC
IQVIA
How matching Electronic Health Records to RWD can improve outcomes
TIME SLOT11:00 - 12:00 a.m.
Enabling PVO in predictive science with the application of Artificial Intelligence
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
Kevin Buckley Sr. VP, Intellectual Property
HUYA Bioscience Int.
10
+ INFO ABOUT OUR SPEAKERS
PREVIOUS PAGE
SPONSOR ROUNDTABLE TOPIC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
TRACK 10 INVESTMENTS & VENTURE
CAPITAL
GO TO MENU NEXT PAGEPREVIOUS PAGE
Introducing The New ‘Investment & Venture Capital’ Track - Proventa International’s latest evolutionary step in developing our signature Strategy Meetings. Now not only providing essential operational strategy solutions but also aiding in equally important fund raising and investment seeking strategy.
11
Daniel Haders II, Ph.D. Managing Director
Healthcare Tech Nex Cubed
Key considerations when approaching in-vestors - investor insights.
ROUNDTABLE TOPIC
TIME SLOT9:00 - 10:00 a.m.
SPEAKER TBC TBC TBC
An investor perspective on building a strong portfolio to best showcase your company.
ROUNDTABLE TOPIC
TIME SLOT3:00 - 4:00 p.m.
SPEAKER TBC TBC TBC
TOPIC TBC
SPONSOR ROUNDTABLE TOPIC
TIME SLOT11:00 - 12:00 a.m.
Current key therapeutic areas which inves-tors are focusing on and why?
ROUNDTABLE TOPIC
TIME SLOT4:30 - 5:30 p.m.
SPEAKER TBC TBC TBC
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE SPONSORSIQVIA is a leading integrated information and technology-enabled healthcare service provider, dedicated to helping its clients improve their clinical, scientific and commercial results. QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes and enhance clinical trial outsourcing through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS solutions span clinical to commercial, bringing clients a unique opportunity to realize the full potential of innovations and advance healthcare outcomes.
Sharp Clinical’s IRT platform manages patient interactions and drug supplies during clinical trials and perform a range of functions for sponsors, drug depots and investigative sites. Our solution includes simple to complex randomization schemes, a warehouse returns system and a supply forecaster which will predict patient enrolment and clinical supply consumption. Sharp Clinical also offers a full complement of clinical trial services, including analytical, formulation development, clinical manufacturing and packaging, storage and distribution. Our creative packaging design capabilities help to save time, costs and ensure on-time deliveries for yourtrial. We have a global dept network that covers every region of the world as well as Qualified Person (QP) services for European distribution.
SanaClis was founded in 2000 by seasoned industry experts all of whom have had executive level positions in leading pharma companies and large global CROs and is one of the very few full-service CROs for clinical trials mainly in Central and Eastern Europe (CEE) offering a comprehensive range of services including: regulatory, clinical monitoring, IMP & CTS management, customs clearance & brokerage, site contracting & payments, project management, quality management, training, central laboratory Russia - including bioequivalence studies, data management, statistics and medical writing. Its facilities, depots and processes meet the most stringent international standards and local requirements. Moreover, SanaClis developed its own software solution to track warehouse operations in real time internally and externally for clients.
VISIT WEBSITE VISIT WEBSITE
CrO Biosciences is an information management consulting firm that provides clients with Inspection Readi-ness, regulatory submission planning and management. We have the expertise necessary to acquire agency approval for regulatory applications in biotechnology, pharmaceutical, and medical device organizations. CrO is a global, woman-owned, operated and controlled company; which consists of regulatory and clinical opera-tions professionals with over 60 years of combined experience. Why settle for working with another company when you can work with the best in the business? Our unique methodologies are up to date with the current rules, regulations, guidances, technologies, and latest industry trends keeping us ahead of the curve every time.
VISIT WEBSITE
VISIT WEBSITEVISIT WEBSITE
PRO-PARTNERS
VISIT WEBSITE VISIT WEBSITE
LEAD
CO-HOSTVISIT WEBSITE
GO TO MENU NEXT PAGEPREVIOUS PAGE12
PROVENTAI N T E R N A T I O N A L
GO TO MENU
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE HOTEL & TRAVEL
207 Fifth Ave, San Diego, CA 92101, USA
DIRECTIONS
AIRPORT TO HOTEL
E-MAIL FOR +INFO
VISIT WEBSITE
PREVIOUS PAGE
13
NEXT PAGE
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
COMPANY
AbbVieAbbVieAcceleron PharmaAcelRxAcerta PharmaAcerta PharmaAcerta PharmaAcerta PharmaAchaogen, Inc.Achillion PharmaceuticalsAduro BiotechAdverumAdverumAkebia TherapeuticsAkebia TherapeuticsAkebia TherapeuticsAldeyra TherapeuticsAlectorAlectorAlkermesAllogene TherappeuticsAlnylam Amarantus Bioscience, Inc.AmgenAmgenAmicus Therapeutics Amylyx PharmaceuticalsAnaptysBioAnnexon BiosciencesAntiva BiosciecesArena PharmaceuticalsAstellas PharmaAstexAstex PharmaceuticalsAstex PharmaceuticalsAstex PharmaceuticalsAstex PharmaceuticalsAstex PharmaceuticalsAtara BiotherapeuticsAudentes TherapeuticsBaxterBeigeneBeigeneBeigeneBeigeneBeigene
JOB TITLE
Director Clinical Data ManagementDirectorDirector, CDMO OperationsDirector-QualityChief Operating OfficerSenior Director, Medical Safety Operations and ExcellenceHead of Medical Safety ScienceMedical Safety DirectorAssociate Director Clinical OperationsSenior Director of Pharmaceutical SciencesDirector Clinical ScienceExecutive Director, Clinical OperationsAssociate DirectorSenior Director, Regulatory CMCDirector, CMC & Operations ManagementSenior Vice President, Chief Development OfficerSenior Director, CMC & Supply ChainVice President, Head of Development OperationsChief Development OfficerAssociate Director, Clinical Supply ChainHead, Clinical Systems & ProgrammingDirector, Clinical Supply ChainChief Scientific OfficerDirector, Observational ResearchSenior Global Trial ManagerAssociate Director, IRT & Global Clinical Supply StrategyGlobal Head of Supply ChainVP Clinical DevelopmentSenior Director, Global Clinical OperationsChief Medical OfficerVice President, Safety and PharmacovigilanceGlobal Head, Real World EvidenceExecutive DirectorSenior Director Clinical OperationsClinical Trial ManagerDirector, Clinical OperationsClinical Trial LeadAssociate Director, Drug SafetyVice President, Drug Safety and PharmacovigilanceSenior Director, Clinical OperationsVice President, Global Patient SafetySenior Director Clinical Business OperationsSenior Manager Clinical Business OperationsSenior Investigator Assoc. Director Safety ScienceSr. Director, PVDS
BeigeneBeigeneBellicum PharmaceuticalsBellicum PharmaceuticalsBill & Melinda Gates Medical Research InstituteBiogenBiogenBiogenBiogenBiogenBiogenBiogenBiogenBiogenBiogen BioMarinBioMarinBiomarinBioMarin PharmaceuticalBioMarin PharmaceuticalBioMarin PharmaceuticalBiomarin Pharmaceuticals Blackthorn TherapeuticsBlackthorn TherapeuticsBluebird Bio Boehringer IngelheimBoehringer IngelheimBoston Scientfic Bristol Meyers SquibbBristol-Myers SquibbBristol-Myers SquibbCalithera BiosciencesCelgeneCelgeneCelgeneCelgeneCelgeneCelgeneClovis OncologyCollegium Pharmaceutical, Inc.Corcept TherapeuticCorcept TherapeuticCorvus PharmaceuticalsCSL BehringCuris Cymabay
Vice President Global Head, Quality & ComplianceHead of Supply Chain OperationsDirector, Safety OperationsExecutive Vice President, Technical OperationsClinical Supply LeaderLead, Clinical Supply CapabilitiesAssociate Director Clinical Drug Supply Senior Manager, Clinical Drug SupplyClinical Drug Supply- Operations Capabilities Management- IRT SpecialistSenior Director, Product and Supply Chain SecurityAssociate Director, Product Protection Program LeadSr. Supervisor, Product and Supply Chain Security R&D Global Strategic SourcingAssociate Direct, Clinical Drug SupplyAssoc Director Strategic Operations and TechMedical DirectorSenior Medical DirectorDirector PVRMVice President, Pharmacovigilance, Medical Writing, Development Sciences QualityAssociate Director, GVP ComplianceMedical DirectorExecutive Director, Head of Data ManagementDirector, Clinical OperationsSenior Director, Biostatistics & Data ManagementDirector of Supply Chain IRT ExpertIRT SpecialistClinical Supply Chain Lead Associate Director Clinical Operations US RegionGlobal Supply Chain Network Planner Co-opHead of Devens Biologics SupplyDirector, Clinical BiomarkersStrategic Program ManagerDirector, Clinical Supply Chain ExcellenceDirector, Strategic Operations Clinical Supply ChainSenior Strategic PlannerSenior Manager, Investigational Material Supply ChainSenior Director, Strategic Program Management, IMSCSenior Director, Clinical OperationsSenior Director, Product DevelopmentQA DirectorQA Associate DirectorDirector Drug SafetyExecutive Director, Pharmacovigilance Operations, Global Clinical Safety & PharmacovigilanceAssociate Director, CMC Medical Director
COMPANY JOB TITLE
GO TO MENU NEXT PAGEPREVIOUS PAGE
2019 ATTENDEES p.1
14
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
COMPANY
CymabayCytokineticsDeciphera PharmaceuticalDenali Therapeutics IncDermiraDermiraDicerna Pharmaceuticals IncAMAG PharmaceuticalsEli Lilly Entasis Therapeutics Entasis Therapeutics ERX PharmaceuticalsEureka Inc.Eureka Inc.ExelixisFibroGenFibroGenFibroGenFibroGenFibroGenFibroGenFibroGenFlexion TherapeuticsForma Therapeutics Gelesis GenentechGenentechGenentechGenentechGenentechGenentechGenentechGenentechGenentechGenentechGenentechGenentech Inc.Genentech/RocheGeronGigaGenGileadGileadGileadGileadGilead SciencesGilead Sciences
JOB TITLE
Clinical ScientistDirector, Clinical OperationsHead of Clinical Supply Operations Senior Director, Reg and CQAVP Clinical OperationsSVP Project ManagementAssociate Director, Supply ChainAMAG PharmaceuticalsSenior Director, CT Material Production & Materials Manag.Associater Director, Supply Chain Clinical Project Leader Chief Medical OfficerDirector, Clinical OperationsDirector Director, Clinical OperationsExecutive Director, Clinical Quality AssuranceSenior Director, Clinical ComplianceAssoc Director, Drug Safety and PharmacovigilanceSVP, Clinical Development, Drug Safety & PhVSenior Director, Clinical ComplianceDirectorSeniorr Manager, Drug Safety ComplianceClinical Supply ChainRDIS Head, Senior Director CTO Country Study SpecialistGlobal Business LeadPV LeaderPrincipal Pharmacovgilance Process LeadGlobal Head, Core Safety ScienceAssociate Group Director, SafetyAssociate Group Medical DirectorMedical Director Safety ScienceGroup Medical Director – Oncology Safety ScienceSenior Group Medical Director & Group Head, Safety SciencePrincipal Safety ScientistGroup DirectorSenior Group Medical Director, Safety ScienceVice President Pharmacovigilance and Drug SafetyDirector of ImmunologyAssociate Director Quality AssuranceR&D Systems AnalystSafety SpecialistDirector, ITAssociate Director, Clinical Operations Director, Clinical Operations
Gilead SciencesGilead SciencesGilead SciencesGlobal Blood TherapeuticsGlobal Solutions For Infectious DiseaseIdeaya BiosciencesIdeaya BiosciencesIDEAYA BiosciencesImmunogen IncyteInovio PharmaceuticalsIonis PharmaceuticalsIovance BiotherapeuticsIovance Biotherapeutics IncIronwood Pharmaceuticals Janssen BiopharmaJazz PharmaceuticalsJazz PharmaceuticalsJohnson & Johnson Kite PharmaMedeor TherapeuticsMenlo TherapeuticsMersana TherapeuticsMyokardiaMyoKardiaMyoKardiaMyoKardiaMyoKardiaMyoKardiaMyokardiaMyokardiaMyovant SciencesNektar TherapeuticsNektar TherapeuticsNektar TherapeuticsNeon TherapeuticsNovapeuticsNovartisPersona BiomePfizerPfizerPfizerPfizerPfizerPharmacyclicsPharmacyclics
Director, Clinical Operations – Early PhaseAssociate DirectorGlobal Clinical Trial ManagerSenior Director, PharmacovigilanceDirector, Clinical OperationsClinical Program DirectorHead of Clinical OperationsSenior DirectorSupply Chain Lead Senior Director, IMSCSenior Vice President, Global QualityVice President & Head of SafetyDirector Clinical, GVP & GLP QualityDirector, Drug SafetyLead, Clinical SupplyClinical Research ManagerSenior Director, Pharmacovigilance and SafetyVice President, Pharmacovigilance & Medical AffairsSenior Manager, Clinical Supply Chain Lead Senior Director, Pharmacovigilance & EpidemiologyDirector, Clinical OperationsVice President, Clinical OperationsDirector, Supply ChainAssociate Director, Clinical OutsourcingSenior Director, Outsourcing and ProcurementAssociate Director, Clinical OpreationsVice President, PharmacovigilanceConsultant PV LeadExecutive Director, Clinical ScienceMedical DirectorSenior Director, Clinical QAGCP Quality ConsultantSenior Director, Clinical Data ManagementClinical Trial ManagerAssociate Director, Clinical OperationsAssociate Director Supply OperationsChief Executive OfficerDirector of Supply ChainChief Executive OfficerExternal Vendor Packaging SchedulerGlobal Clinical Supply FellowClinical Research Sourcing StrategistSenior Manager, IVRS Global Operations TeamLead, IRT Data StewardSr. Director, Section Head, Drug Safety & Pharmacovigilance Ops.Associate Medical Director
COMPANY JOB TITLE
GO TO MENU NEXT PAGEPREVIOUS PAGE
2019 ATTENDEES p.2
15
PROVENTAI N T E R N A T I O N A L
CLINICALOPERATIONS PHARMACOVIGILANCECLINICALTRIALSUPPLYCHAINCLINICALOPERATIONS CLINICALTRIALSUPPLYCHAIN PHARMACOVIGILANCE
COMPANY
PharmacyclicsPharmacyclicsPharmacyclicsPharmacyclics LLC., an AbbVie CompanyPharmacyclics, An AbbVie CompanyPieris Pharmaceuticals Pieris Pharmaceuticals Portola Inc.Portola Inc.Portola Inc.Proteostasis TherapeuticsPTC Therapeutics, Inc.Quark PharmaceuticalsQuark PharmaceuticalsQuark PharmaceuticalsQuark PharmaceuticalsQuark PharmaceuticalsRegeneron Pharmaceuticals, Inc.RocheRubius TherapeuticsSamumed Sangamo TherapeuticsSangamo TherapeuticsSanofiSanofiSanofiSantenSanten INCSarepta TherapeuticsSeres Therapeutics
JOB TITLE
Senior Director, Clinical QAHead of Clinical ScienceAssociate DirectorAssociate Director, DSPV Case ManagementAssociate Director, Clinical OperationsSenior Director, Clinical Operations Senior Director, Supply Chain OperationsExecutive Director, Clinical OperationsProcurement Process LeadProcurement ManagerAssociate Director, Clinical Drug Supply and IRTClinical Supplies & Desginated RepresentativeDirector, Clinical OperationsSenior Director Clinical OperationsClinical Program ManagerHead of PharmacovigilanceLead, Drug AssociateDirector, Supply Chain OperationsSafety ScienceSenior Director of Supply ChainAssociate Director, Clinical OperationsAssociate Director Clinical OperationsAssociate Director, Clinical ScienceProject Excellence and Innovation Head, Clinical Supply Chain Clinical Supply Chain Project LeaderClinical Supply Chain Project LeaderAssociate Director, Clinical ProgramDirector, Global PharmacovigilanceAssociate Director, Global Supply Chain & LogisticsSupply Chain Lead
ShireShire Sunovion Sunovion Symic BioSymic BioTakedaTakedaTakedaTakedaTakedaTakeda Takeda Pharmaceutical Company Ltd.TARIS BiomedicalTetraphase PharmaceuticalsTheravanceTheravanceTitan PharmaceuticalsTricida IncUltragenyxUnity BiotechnologyUnity BiotechnologyUniversity of San FranciscoZogenixZogenixZogenix
Clinical & Medical Category LeadHead of Clinical Supply Chain Senior Director, Clinical Trial Materials ManagementAssociate Director Strategic SourcingSenior Director, TranslationSenior Director, Quality AssuranceDirector, Supply ChainGlobal Category Manager ProcurementHead of Global Direct Materials ProcurementDirector, Clinical Supply Strategy Vice President Medical Safety, Global Head Signal and Risk Management Lead, Clinical QAHead of Pharmaceutical Sciences Systems, AmericasSenior Director, Product Development and Technical OperationsHead of Global Supply ChainVice President BiometricsDirector, Clinical Data ManagementDirector, REMS Program & Drug Safety ComplianceHead of Drug Safety & PharmacovigilanceAssociate Director, Global Supply ChainSr. Clinical Program Manager, Clinical OperationsDirector Clinical OperationsResearch Fellow UCSFDirector, Clinical Process Improvement & InnovationHead of Clinical OperationsAssociate Director, Clinical Science Liaison Clinical Development
COMPANY JOB TITLE
GO TO MENUPREVIOUS PAGE
2019 ATTENDEES p.3
16